Keywords
hyperglycemia
autoinmune disorder
insulin resistance
autoinmune disorder
insulin resistance
How to Cite
Gómez, A. M., Gómez, C., Leguizamón, G., & Imitola, A. (2018). Refractory hyperglycemia due to insulin type B resistance: diagnostic challenge. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 5(4), 48–51. https://doi.org/10.53853/encr.5.4.455
Abstract
Insulin resistance type B is an entity characterized by hyperglycemia refractary to insulin associated to autoinmune disease. The prevalence is low, however, well-timed diagnose is fundamental because of the favorable impact of treatment in clinical outcomes. 116 case reports of insulin resistance type B have been described in worlwide literature. We describe the case of a patient with insulin resistance type B, who achieved improvement of glucose control registered by continuos glucose monitoring after initiation of inmunomodulator treatment.
References
1. Willard D, Stevenson M, and Steenkamp D. Type B insulin resistance síndrome. Curr Opin Endocrinol Diabetes Obes. 2016, 23:318–323.
2. Malek R, Chong A, Lupsa B, Lungu A, Cochran A, Soos M, et al. Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies. J Clin Endocrinol Metab. 2010, 95: 3641–3647.
3. Zhang S, Wang G and Wang J. Type B insulin resistance syndrome induced by systemic lupus erythematosus and successfully treated with intravenous immunoglobulin: case report and systematic review. Clin Rheumatol. 2013, 32:181-188.
4. Arioglu E, Andewelt A, Diabo C, Bell M, Taylor S, And Gorden P. Clinical Course of the Syndrome of Autoantibodies to the Insulin Receptor (Type B Insulin Resistance): A 28-Year Perspective. Medicine. 2002, 81:87–100.
2. Malek R, Chong A, Lupsa B, Lungu A, Cochran A, Soos M, et al. Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies. J Clin Endocrinol Metab. 2010, 95: 3641–3647.
3. Zhang S, Wang G and Wang J. Type B insulin resistance syndrome induced by systemic lupus erythematosus and successfully treated with intravenous immunoglobulin: case report and systematic review. Clin Rheumatol. 2013, 32:181-188.
4. Arioglu E, Andewelt A, Diabo C, Bell M, Taylor S, And Gorden P. Clinical Course of the Syndrome of Autoantibodies to the Insulin Receptor (Type B Insulin Resistance): A 28-Year Perspective. Medicine. 2002, 81:87–100.
Authors must state that they reviewed, validated and approved the manuscript's publication. Moreover, they must sign a model release that should be sent. A copy may be reviewed here